{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:34:24Z","timestamp":1790386464684,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1615\/19"],"award-info":[{"award-number":["1615\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["20\\u20130238"],"award-info":[{"award-number":["20\\u20130238"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM144393"],"award-info":[{"award-number":["R01GM144393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees","doi-asserted-by":"publisher","award":["OoR2022\/100004"],"award-info":[{"award-number":["OoR2022\/100004"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.146066","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T07:33:52Z","timestamp":1752651232000},"page":"146066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P4","title":["Neuroprotective functions of the APPI domain of amyloid precursor protein (APP): Reducing KLK6-mediated APP cleavage and A\u03b242 formation and aggregation"],"prefix":"10.1016","volume":"320","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-2111","authenticated-orcid":false,"given":"Shiran","family":"Lacham-Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1967-3979","authenticated-orcid":false,"given":"Ofek","family":"Oren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4663-2076","authenticated-orcid":false,"given":"Maya","family":"Rabinovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niv","family":"Papo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2025.146066_bb0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1042\/BST0350416","article-title":"The APP family of proteins: similarities and differences","volume":"35","author":"Walsh","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1326-1-5","article-title":"The amyloid precursor protein: beyond amyloid","volume":"1","author":"Zheng","year":"2006","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146066_bb0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0378-1119(90)90310-N","article-title":"Genomic organization of the human amyloid beta-protein precursor gene","volume":"87","author":"Yoshikai","year":"1990","journal-title":"Gene"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.146066_bb0020","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.febslet.2013.05.010","article-title":"The amyloid precursor protein: a biochemical enigma in brain development, function and disease","volume":"587","author":"Nalivaeva","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1749-6632.1996.tb34433.x","article-title":"APP gene family. Alternative splicing generates functionally related isoforms","volume":"777","author":"Sandbrink","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146066_bb0030","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1523\/JNEUROSCI.13-07-03136.1993","article-title":"Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system","volume":"13","author":"Sisodia","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","article-title":"Expression of APP pathway mRNAs and proteins in Alzheimer\u2019s disease","volume":"1161","author":"Matsui","year":"2007","journal-title":"Brain Res."},{"issue":"4957","key":"10.1016\/j.ijbiomac.2025.146066_bb0040","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.2111579","article-title":"Relation of neuronal APP-751\/APP-695 mRNA ratio and neuritic plaque density in Alzheimer\u2019s disease","volume":"248","author":"Johnson","year":"1990","journal-title":"Science"},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2025.146066_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0169-328X(92)90122-R","article-title":"Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer\u2019s disease and other neurological disorders","volume":"15","author":"Tanaka","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146066_bb0050","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146066_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jnr.490280109","article-title":"Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion","volume":"28","author":"Breen","year":"1991","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146066_bb0060","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1471-4159.1997.68031164.x","article-title":"Identification of heparin-binding domains in the amyloid precursor protein of Alzheimer\u2019s disease by deletion mutagenesis and peptide mapping","volume":"68","author":"Clarris","year":"1997","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146066_bb0065","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.1037392100","article-title":"Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2","volume":"100","author":"Kimberly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5440","key":"10.1016\/j.ijbiomac.2025.146066_bb0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146066_bb0075","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1096\/fj.05-5032fje","article-title":"Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624)","volume":"20","author":"Shaked","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.969547","article-title":"Amyloid precursor protein (APP) and amyloid beta (Abeta) interact with cell adhesion molecules: implications in Alzheimer\u2019s disease and normal physiology","volume":"10","author":"Pfundstein","year":"2022","journal-title":"Front. cell dev. biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146066_bb0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74833","article-title":"Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer\u2019s disease","volume":"3","author":"Lorenzo","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146066_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","article-title":"Mitochondrial targeting and a novel transmembrane arrest of Alzheimer\u2019s amyloid precursor protein impairs mitochondrial function in neuronal cells","volume":"161","author":"Anandatheerthavarada","year":"2003","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146066_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109134","article-title":"Axonal generation of amyloid-beta from palmitoylated APP in mitochondria-associated endoplasmic reticulum membranes","volume":"35","author":"Bhattacharyya","year":"2021","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146066_bb0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer\u2019s disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"48","key":"10.1016\/j.ijbiomac.2025.146066_bb0105","doi-asserted-by":"crossref","first-page":"20324","DOI":"10.1073\/pnas.0911281106","article-title":"Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide","volume":"106","author":"Hu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.146066_bb0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jneuroim.2006.05.022","article-title":"Potential scope of action of tissue kallikreins in CNS immune-mediated disease","volume":"178","author":"Scarisbrick","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146066_bb0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","article-title":"Regulation of APP cleavage by alpha-, beta- and gamma-secretases","volume":"483","author":"Nunan","year":"2000","journal-title":"FEBS Lett."},{"issue":"40","key":"10.1016\/j.ijbiomac.2025.146066_bb0120","doi-asserted-by":"crossref","first-page":"25135","DOI":"10.1074\/jbc.272.40.25135","article-title":"Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer\u2019s disease brain","volume":"272","author":"Little","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146066_bb0125","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0006-291X(03)01271-3","article-title":"Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors","volume":"307","author":"Magklara","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"35","key":"10.1016\/j.ijbiomac.2025.146066_bb0130","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146066_bb0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0009-9120(00)00185-5","article-title":"Human kallikrein 6 as a biomarker of alzheimer\u2019s disease","volume":"33","author":"Diamandis","year":"2000","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-019-0168-6","article-title":"Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET","volume":"8","author":"Goldhardt","year":"2019","journal-title":"Transl. neurodegener."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146066_bb0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1471-4159.1999.0730742.x","article-title":"Laminin 1 attenuates beta-amyloid peptide Abeta(1-40) neurotoxicity of cultured fetal rat cortical neurons","volume":"73","author":"Drouet","year":"1999","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146066_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(96)13147-5","article-title":"Laminin inhibits amyloid-beta-peptide fibrillation","volume":"218","author":"Bronfman","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146066_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1471-4159.2010.07081.x","article-title":"Alpha-secretase in Alzheimer\u2019s disease: molecular identity, regulation and therapeutic potential","volume":"116","author":"Lichtenthaler","year":"2011","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146066_bb0160","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1172\/JCI116863","article-title":"Protease nexin-2\/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa","volume":"92","author":"Schmaier","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146066_bb0165","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1042\/BJ20151410","article-title":"Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy","volume":"473","author":"Cohen","year":"2016","journal-title":"Biochem. J."},{"issue":"33","key":"10.1016\/j.ijbiomac.2025.146066_bb0170","doi-asserted-by":"crossref","first-page":"12663","DOI":"10.1074\/jbc.RA117.000871","article-title":"A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering","volume":"293","author":"Sananes","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146066_bb0175","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/1878-0261.13513","article-title":"Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers","volume":"17","author":"Sananes","year":"2023","journal-title":"Mol. Oncol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.146066_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163969","article-title":"Kallikrein-related peptidase 6 is associated with the tumour microenvironment of pancreatic ductal adenocarcinoma","volume":"13","author":"Candido","year":"2021","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.146066_bb0185","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1021\/acschemneuro.3c00208","article-title":"APPI-derived cyclic peptide enhances Abeta42 aggregation and reduces Abeta42-mediated membrane destabilization and cytotoxicity","volume":"14","author":"Lacham-Hartman","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146066_bb0190","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1074\/jbc.273.9.5013","article-title":"Relative increase in Alzheimer\u2019s disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain","volume":"273","author":"Moir","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146066_bb0195","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-2010-091363","article-title":"An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons","volume":"20","author":"Agholme","year":"2010","journal-title":"J. Alzheimer\u2019s dis.\u202f: JAD"},{"issue":"6156","key":"10.1016\/j.ijbiomac.2025.146066_bb0200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/331525a0","article-title":"A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors","volume":"331","author":"Ponte","year":"1988","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146066_bb0205","article-title":"The signal peptide of the amyloid precursor protein forms amyloid-like aggregates and enhances A\u03b242 aggregation","volume":"2","author":"Gadhav","year":"2021","journal-title":"Cell Rep. Phys. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146066_bb0210","doi-asserted-by":"crossref","first-page":"14502","DOI":"10.18632\/oncotarget.13264","article-title":"KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species","volume":"8","author":"Pampalakis","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146066_bb0215","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer\u2019s disease beta-amyloid peptides: detection of amyloid aggregation in solution","volume":"2","author":"LeVine","year":"1993","journal-title":"Protein science\u202f: a publication of the Protein Society"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146066_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129087","article-title":"Structure-based peptide design to modulate amyloid Beta aggregation and reduce cytotoxicity","volume":"10","author":"Kumar","year":"2015","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.146066_bb0225","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1042\/BCJ20180247","article-title":"An Abeta42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability","volume":"475","author":"Oren","year":"2018","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146066_bb0230","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1006\/jmbi.1996.0133","article-title":"Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer\u2019s amyloid peptide Abeta","volume":"256","author":"Wood","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"44","key":"10.1016\/j.ijbiomac.2025.146066_bb0235","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers","volume":"283","author":"Glabe","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146066_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020575","article-title":"Polymorphic structures of Alzheimer's beta-amyloid globulomers","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146066_bb0245","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2008.01.010","article-title":"Abeta-globulomers are formed independently of the fibril pathway","volume":"30","author":"Gellermann","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146066_bb0250","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer\u2019s disease: current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimer\u2019s dis.\u202f: JAD"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146066_bb0255","article-title":"Alzheimer\u2019s disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"37","key":"10.1016\/j.ijbiomac.2025.146066_bb0260","doi-asserted-by":"crossref","first-page":"19590","DOI":"10.1074\/jbc.M115.691840","article-title":"Amyloid-beta(1-42) aggregation initiates its cellular uptake and cytotoxicity","volume":"291","author":"Jin","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146066_bb0265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.1799","article-title":"Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils","volume":"17","author":"Ahmed","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146066_bb0270","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1096\/fj.201900604R","article-title":"High molecular weight amyloid beta(1-42) oligomers induce neurotoxicity via plasma membrane damage","volume":"33","author":"Yasumoto","year":"2019","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146066_bb0275","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.expneurol.2005.08.001","article-title":"Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides","volume":"196","author":"Awasthi","year":"2005","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146066_bb0280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146066_bb0285","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1128\/aem.63.6.2421-2431.1997","article-title":"Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain","volume":"63","author":"Roth","year":"1997","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0290","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.fob.2015.09.002","article-title":"Analysis by a highly sensitive split luciferase assay of the regions involved in APP dimerization and its impact on processing","volume":"5","author":"Decock","year":"2015","journal-title":"FEBS Open Bio."},{"issue":"42","key":"10.1016\/j.ijbiomac.2025.146066_bb0295","doi-asserted-by":"crossref","first-page":"28943","DOI":"10.1074\/jbc.M109.038646","article-title":"Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production","volume":"284","author":"Eggert","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.146066_bb0300","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jcc.27100","article-title":"Characterization of the role of Kunitz-type protease inhibitor domain in dimerization of amyloid precursor protein","volume":"44","author":"Byun","year":"2023","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146066_bb0305","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1120416","article-title":"Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils","volume":"10","author":"Muschol","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.146066_bb0315","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1007\/s00018-021-03954-z","article-title":"Amyloid beta structural polymorphism, associated toxicity and therapeutic strategies","volume":"78","author":"Oren","year":"2021","journal-title":"Cel. mol. life sci. : CMLS"},{"issue":"47","key":"10.1016\/j.ijbiomac.2025.146066_bb0320","doi-asserted-by":"crossref","first-page":"36884","DOI":"10.1074\/jbc.M110.171348","article-title":"Determinants of affinity and proteolytic stability in interactions of Kunitz family protease inhibitors with mesotrypsin","volume":"285","author":"Salameh","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0325","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s42003-019-0612-2","article-title":"Autocatalytic amplification of Alzheimer-associated Abeta42 peptide aggregation in human cerebrospinal fluid","volume":"2","author":"Frankel","year":"2019","journal-title":"Commun. biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146066_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112052","article-title":"Feasibility of beta-sheet breaker peptide-H102 treatment for Alzheimer's disease based on beta-amyloid hypothesis","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.146066_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1874070701105010039","article-title":"Short peptides as inhibitors of amyloid aggregation","volume":"5","author":"Neddenriep","year":"2011","journal-title":"Open Biotechnol. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146066_bb0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/156802607779318262","article-title":"Disrupting beta-amyloid aggregation for Alzheimer disease treatment","volume":"7","author":"Estrada","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146066_bb0345","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/cn900019r","article-title":"Effects of peptides derived from terminal modifications of the abeta central hydrophobic core on abeta fibrillization","volume":"1","author":"Bett","year":"2010","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146066_bb0350","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ab.2012.11.025","article-title":"Kinetic studies of inhibition of the amyloid beta (1-42) aggregation using a ferrocene-tagged beta-sheet breaker peptide","volume":"434","author":"Zhang","year":"2013","journal-title":"Anal. Biochem."},{"issue":"40","key":"10.1016\/j.ijbiomac.2025.146066_bb0355","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146066_bb0360","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbadis.2008.06.003","article-title":"Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake","volume":"1782","author":"Chafekar","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146066_bb0365","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.3892\/mmr.2017.7203","article-title":"Amyloid beta-42 induces neuronal apoptosis by targeting mitochondria","volume":"16","author":"Han","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"27","key":"10.1016\/j.ijbiomac.2025.146066_bb0370","doi-asserted-by":"crossref","first-page":"24562","DOI":"10.1074\/jbc.M202392200","article-title":"Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system","volume":"277","author":"Bernett","year":"2002","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025066231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025066231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:42:13Z","timestamp":1777192933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025066231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":74,"alternative-id":["S0141813025066231"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146066","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective functions of the APPI domain of amyloid precursor protein (APP): Reducing KLK6-mediated APP cleavage and A\u03b242 formation and aggregation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"146066"}}